Bioequivalence Study of Perampanel Tablets 12 mg
NCT06450223
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Interventions
DRUG:
Perampanel 12 MG
DRUG:
Fycompa 12 mg film-coated tablets
Sponsor
Humanis Saglık Anonim Sirketi